Drug:
Reaction: OVERDOSE
20250101 - 20251231
No. 2501 - 2600
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 2501 | 25312698 |
GB |
||
Completed suicide, Respiratory arrest, Overdose, Cardiac arrest, |
||||
PREGABALIN, DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), PROPRANOLOL HYDROCHLORIDE, BACLOFEN, |
||||
| 2502 | 25313920 |
US |
2 | |
Heart rate increased, Overdose, |
||||
ALBUTEROL SULFATE, |
||||
| 2503 | 25313964 |
US |
53 | 2 |
Overdose, |
||||
DULAGLUTIDE, |
||||
| 2504 | 25314132 |
US |
14 | 2 |
Product use in unapproved indication, Overdose, Wrong technique in product usage process, |
||||
CETIRIZINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE, |
||||
| 2505 | 25314340 |
US |
2 | |
Overdose, |
||||
FAMOTIDINE, |
||||
| 2506 | 25314813 |
GB |
47 | 2 |
Overdose, Death, |
||||
DULOXETINE HYDROCHLORIDE, DULOXETIN HYDROCHLORIDE, DULOXETINE, FLUOXETINE HYDROCHLORIDE, FLUOXETINE, TRAMADOL HYDROCHLORIDE, LIDOCAINE HYDROCHLORIDE, LIDOCAINE HYDROCHLORIDE ANHYDROUS, PREGABALIN, |
||||
| 2507 | 25315240 |
ES |
21 | 1 |
Arrhythmia, Generalised tonic-clonic seizure, Coma, Toxicity to various agents, Overdose, |
||||
LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, PROPRANOLOL HYDROCHLORIDE, METHYLPHENIDATE, METHYLPHENIDATE HYDROCHLORIDE, |
||||
| 2508 | 25315511 |
GB |
||
Completed suicide, Respiratory arrest, Cardiac arrest, Overdose, |
||||
PREGABALIN, BACLOFEN, DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), PROPRANOLOL HYDROCHLORIDE, |
||||
| 2509 | 25303961 |
CA |
||
Bursitis, Fall, Finger deformity, Folliculitis, Gastrooesophageal reflux disease, Hepatitis, Hypoaesthesia, Inflammation, Injury, Liver function test increased, Mobility decreased, Muscular weakness, Neck pain, Pain in extremity, Pneumonia, Off label use, Intentional product use issue, Intentional product use issue, Overdose, Underdose, Intentional product use issue, |
||||
ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, ERENUMAB-AOOE, ERENUMAB-AOOE, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, |
||||
| 2510 | 25304080 |
US |
2 | |
Overdose, Product use in unapproved indication, |
||||
CETIRIZINE HYDROCHLORIDE, EPINEPHRINE, HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE, HYDROXYZINE HYDROCHLORIDE ORAL, VENLAFAXINE HYDROCHLORIDE, DOXEPIN, DOXEPIN HYDROCHLORIDE, FAMOTIDINE, OMALIZUMAB, MONTELUKAST SODIUM, PREDNISONE, LORATADINE, LORATADINE TABLET, DIPHENHYDRAMINE HYDROCHLORIDE, |
||||
| 2511 | 25304353 |
FR |
||
Analgesic drug level increased, Overdose, |
||||
ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 2512 | 25304745 |
QA |
25 | 1 |
Drug interaction, Pancreatitis acute, Overdose, |
||||
MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, BASILIXIMAB, PREDNISONE, |
||||
| 2513 | 25304784 |
FR |
25 | 1 |
Toxicity to various agents, Impulse-control disorder, Hallucination, visual, Suicidal ideation, Intentional self-injury, Suicide attempt, Intentional product misuse, Self-medication, Substance use, Overdose, Somnolence, Nausea, Toxicity to various agents, |
||||
CLONAZEPAM, CLONAZEPAM, CLONAZEPAM, DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), PREGABALIN, PREGABALIN, NITROUS OXIDE, ALCOHOL, ETHYL ALCOHOL, ISOPROPYL ALCOHOL, |
||||
| 2514 | 25304835 |
US |
72 | 2 |
Loss of consciousness, Unresponsive to stimuli, Snoring, Bruxism, Tachycardia, Hypoxia, Electrocardiogram QRS complex prolonged, Overdose, Hypotension, Vomiting, |
||||
BACLOFEN, |
||||
| 2515 | 25304920 |
AU |
||
Acute hepatic failure, Pneumonia, Hallucination, Immobile, Adverse event, Dysuria, Urinary retention, Pain, Product dispensing error, Constipation, Overdose, Tachycardia, Abdominal pain, Decreased appetite, |
||||
BUPRENORPHINE, PALIPERIDONE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 2516 | 25305212 |
SI |
87 | 2 |
Mucosal inflammation, Pancytopenia, Medication error, Prescribed overdose, Overdose, |
||||
METHOTREXATE, METHOTREXATE SODIUM, SPIRONOLACTONE, DENOSUMAB, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, DABIGATRAN ETEXILATE MESYLATE, DABIGATRAN ETEXILATE, DABIGATRAN ETEXILATE MESYLATE, DABIGATRAN ETEXILATE, ROSUVASTATIN CALCIUM, ROSUVASTATIN CALCIUM, |
||||
| 2517 | 25305572 |
US |
79 | 2 |
Alopecia, Overdose, |
||||
MINOXIDIL, MINOXIDIL, |
||||
| 2518 | 25305646 |
US |
38 | 2 |
Overdose, Substance abuse, |
||||
NALTREXONE, MIRTAZAPINE, |
||||
| 2519 | 25306178 |
EU |
2 | |
Upper airway obstruction, Freezing phenomenon, Withdrawal syndrome, Fatigue, Anxiety, Drug ineffective, Chest discomfort, Joint stiffness, Throat irritation, Dyspnoea, Initial insomnia, Dysphagia, Wrong technique in product usage process, Overdose, Product use issue, Product prescribing error, |
||||
CARBIDOPA AND LEVODOPA, RASAGILINE MESYLATE, ROTIGOTINE, OXAZEPAM, MELATONIN, OXAZEPAM, |
||||
| 2520 | 25307118 |
US |
63 | 2 |
Insomnia, Arthralgia, Overdose, Dyspepsia, Fatigue, |
||||
TIRZEPATIDE, |
||||
| 2521 | 25307281 |
US |
34 | 1 |
Overdose, |
||||
NALTREXONE, |
||||
| 2522 | 25307434 |
ES |
72 | 2 |
Suicide attempt, Overdose, Intentional overdose, Intentional overdose, |
||||
LORAZEPAM, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, SERTRALINE HYDROCHLORIDE, OMEPRAZOLE MAGNESIUM, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, LEVETIRACETAM, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, LEVETIRACETAM IN SODIUM CHLORIDE, LACOSAMIDE, |
||||
| 2523 | 25307441 |
GB |
5 | 1 |
Overdose, Respiratory failure, Respiratory acidosis, Pericardial effusion, Drug abuse, Ascites, |
||||
PREGABALIN, MIRTAZAPINE, DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), FENTANYL, MORPHINE, METHADONE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, |
||||
| 2524 | 25307616 |
US |
||
Overdose, |
||||
ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, |
||||
| 2525 | 25307619 |
DE |
83 | 2 |
Oral candidiasis, Immune system disorder, Circulatory collapse, Overdose, Dysphagia, Oropharyngeal pain, Stomatitis, Hypophagia, Fluid intake reduced, |
||||
METHOTREXATE SODIUM, |
||||
| 2526 | 25307716 |
FR |
21 | 2 |
Analgesic drug level increased, Overdose, |
||||
ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 2527 | 25307777 |
CA |
1 | |
Depressed mood, Insomnia, Neglect of personal appearance, Poor personal hygiene, Abdominal discomfort, Hallucination, auditory, Substance use, Therapeutic response shortened, Inappropriate schedule of product administration, Treatment noncompliance, Overdose, |
||||
VALPROIC ACID, ARIPIPRAZOLE, ARIPIPRAZOLE, ARIPIPRAZOLE, ARIPIPRAZOLE, LEVOTHYROXINE, |
||||
| 2528 | 25307923 |
FR |
1 | 1 |
Peripheral ischaemia, Incorrect dose administered, Overdose, |
||||
NOREPINEPHRINE (BITARTRATE), NOREPINEPHRINE, NOREPINEPHRINE BITARTRATE, NOREPINEPHRINE (BITARTRATE), NOREPINEPHRINE, NOREPINEPHRINE BITARTRATE, NOREPINEPHRINE (BITARTRATE), NOREPINEPHRINE, NOREPINEPHRINE BITARTRATE, NOREPINEPHRINE (BITARTRATE), NOREPINEPHRINE, NOREPINEPHRINE BITARTRATE, |
||||
| 2529 | 25308084 |
GB |
36 | 2 |
Acute kidney injury, Overdose, |
||||
TIRZEPATIDE, |
||||
| 2530 | 25308116 |
US |
||
Tremor, Overdose, |
||||
VALBENAZINE, |
||||
| 2531 | 25308204 |
GB |
40 | 1 |
Suicidal ideation, Overdose, Drug screen positive, |
||||
MORPHINE SULFATE, DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), SILDENAFIL CITRATE, SILDENAFIL, SILDENAFIL POWDER,, |
||||
| 2532 | 25312539 |
31 | 1 | |
Overdose, |
||||
| 2533 | 25312925 |
21 | 1 | |
Overdose, Suicidal ideation, |
||||
ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 2534 | 25313046 |
75 | 1 | |
Mental status changes, Unresponsive to stimuli, Overdose, Drug abuse, |
||||
| 2535 | 25298224 |
US |
74 | 2 |
Anastomotic ulcer, Melaena, Gastric fistula, Intentional product misuse, Overdose, |
||||
NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, |
||||
| 2536 | 25298227 |
IN |
1 | |
Drug dependence, Drug abuse, Overdose, Syncope, Drug ineffective, |
||||
LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HCL, VALPROIC ACID, RISPERIDONE, LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HCL, LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HCL, |
||||
| 2537 | 25298640 |
ZA |
||
Hospitalisation, Condition aggravated, Fistula, Overdose, |
||||
INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, |
||||
| 2538 | 25298675 |
US |
84 | |
Overdose, |
||||
DULAGLUTIDE, |
||||
| 2539 | 25298844 |
AU |
30 | 1 |
Loss of consciousness, Pneumonia, Respiratory depression, Respiratory failure, Toxicity to various agents, Overdose, |
||||
PREGABALIN, METHADONE, TEMAZEPAM, |
||||
| 2540 | 25298977 |
US |
2 | |
Product dose omission issue, Wrong technique in product usage process, Surgery, Product lot number issue, Overdose, Hypersensitivity, |
||||
BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, |
||||
| 2541 | 25299116 |
RO |
58 | 2 |
Delayed graft function, Nephropathy toxic, Oliguria, Hyperkalaemia, Metabolic acidosis, Overdose, |
||||
TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, PREDNISONE, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, |
||||
| 2542 | 25299383 |
US |
||
Toxicity to various agents, Respiratory distress, Overdose, Respiratory acidosis, Cardiac arrest, Mental status changes, Electrocardiogram QT prolonged, Ventricular tachycardia, |
||||
BACLOFEN, BACLOFEN, |
||||
| 2543 | 25299390 |
US |
74 | 2 |
Melaena, Anastomotic ulcer, Gastric fistula, Overdose, Intentional product misuse, |
||||
NAPROXEN, NAPROXEN SODIUM, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, COLCHICINE, |
||||
| 2544 | 25299576 |
US |
21 | 2 |
Overdose, Impulsive behaviour, |
||||
ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 2545 | 25299775 |
JP |
86 | 1 |
Death, Overdose, |
||||
SODIUM ZIRCONIUM CYCLOSILICATE, LANSOPRAZOLE, FEBUXOSTAT, FEBUXOSTAT TABLETS 40 MG, FEBUXOSTAT TABLETS 80 MG, FUROSEMIDE, DAPRODUSTAT, SILODOSIN, BETHANECHOL CHLORIDE, |
||||
| 2546 | 25301015 |
ES |
21 | 1 |
Arrhythmia, Overdose, Toxicity to various agents, Generalised tonic-clonic seizure, Coma, |
||||
LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, PROPRANOLOL HYDROCHLORIDE, METHYLPHENIDATE, METHYLPHENIDATE HYDROCHLORIDE, |
||||
| 2547 | 25301999 |
ES |
21 | 1 |
Arrhythmia, Overdose, Toxicity to various agents, Generalised tonic-clonic seizure, Coma, |
||||
LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, PROPRANOLOL HYDROCHLORIDE, METHYLPHENIDATE, METHYLPHENIDATE HYDROCHLORIDE, |
||||
| 2548 | 25302341 |
IT |
22 | 2 |
Stab wound, Overdose, |
||||
ALPRAZOLAM, |
||||
| 2549 | 25302346 |
CN |
56 | 2 |
Hallucination, Disorganised speech, Mania, Overdose, |
||||
| 2550 | 25302594 |
EU |
43 | 1 |
Myoclonic epilepsy, Status epilepticus, Disturbance in attention, Wrong product administered, Blood potassium decreased, Red blood cell sedimentation rate increased, Off label use, Overdose, Drug ineffective, |
||||
BRIVARACETAM, BRIVARACETAM, BRIVARACETAM, TAMSULOSIN HYDROCHLORIDE, FOLIC ACID, MELATONIN, MIDAZOLAM, MIDAZOLAM HYDROCHLORIDE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, DIMENHYDRINATE, TOPIRAMATE, TOPIRAMATE SPINKLE, |
||||
| 2551 | 25302759 |
US |
69 | 1 |
Unresponsive to stimuli, Miosis, Sinus bradycardia, Atrioventricular dissociation, Diastolic dysfunction, Sedation complication, Mental status changes, Hypoxia, Respiration abnormal, Overdose, |
||||
MORPHINE SULFATE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, FENTANYL, QUININE, |
||||
| 2552 | 25302762 |
US |
33 | 1 |
Toxicity to various agents, Road traffic accident, Impaired driving ability, Overdose, Drug abuse, |
||||
HYDROCODONE BITARTRATE, FENTANYL, DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), GABAPENTIN, |
||||
| 2553 | 25294979 |
US |
1 | |
Dizziness, Burning sensation, Fatigue, Blood pressure increased, Incorrect dose administered, Overdose, |
||||
CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, |
||||
| 2554 | 25290302 |
AU |
||
Pneumonia, Urinary retention, Adverse event, Tachycardia, Constipation, Acute hepatic failure, Overdose, Product dispensing error, Immobile, |
||||
BUPRENORPHINE, PALIPERIDONE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 2555 | 25290438 |
CA |
||
Crohn^s disease, Overdose, Drug ineffective, |
||||
INFLIXIMAB, INFLIXIMAB, PREDNISONE, |
||||
| 2556 | 25290633 |
US |
63 | 2 |
Pulmonary arterial hypertension, Loss of consciousness, Dyspnoea, Fluid retention, Vomiting, Flushing, Gastroenteritis viral, Pain, Patient dissatisfaction with treatment, Drug tolerance decreased, Overdose, Abdominal discomfort, Diarrhoea, Headache, Rash, Pruritus, Urticaria, Swelling face, Mouth swelling, Eye swelling, Infusion site pain, Lymphadenopathy, Nausea, Abdominal distension, Oedema peripheral, |
||||
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, VITAMIN E, MAGNESIUM, AMIODARONE HYDROCHLORIDE, SILDENAFIL CITRATE, SILDENAFIL, SILDENAFIL POWDER,, MACITENTAN, OXYGEN, 0XYGEN, ERGOCALCIFEROL, FAMOTIDINE, TORSEMIDE, LORATADINE, LORATADINE ORAL, SELEXIPAG, SELEXIPAG, |
||||
| 2557 | 25292472 |
US |
70 | 2 |
Suicide attempt, Overdose, Product use in unapproved indication, |
||||
ZOLPIDEM TARTRATE, DULOXETINE HYDROCHLORIDE, DULOXETIN HYDROCHLORIDE, DULOXETINE, LUMATEPERONE, |
||||
| 2558 | 25312240 |
US |
||
Aortic dissection, Thrombosis, Dementia, Fall, Pelvic fracture, Blood pressure increased, Overdose, Decreased appetite, Dysphagia, Asthenia, |
||||
HUMAN INSULIN, INSULIN ASPART, |
||||
| 2559 | 25285570 |
TR |
||
Disorientation, Oxygen saturation decreased, Dyspnoea, Tachycardia, Hypertension, Underdose, Overdose, |
||||
RITUXIMAB-ABBS, RITUXIMAB-ABBS, ENOXAPARIN SODIUM, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, MEROPENEM, IPRATROPIUM BROMIDE, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, FUROSEMIDE, FOLIC ACID, |
||||
| 2560 | 25285778 |
CA |
||
Cerebrovascular accident, Overdose, |
||||
NICOTINE, NICOTINE POLACRILEX, |
||||
| 2561 | 25285938 |
US |
60 | 1 |
Cholelithiasis, Malnutrition, Abdominal pain, Diarrhoea, Vomiting, Impaired gastric emptying, Nausea, Dyspepsia, Constipation, Dehydration, Anxiety, Overdose, Inappropriate schedule of product administration, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, SEMAGLUTIDE, SEMAGLUTIDE, LIRAGLUTIDE, LIRAGLUTIDE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, GLIPIZIDE, INSULIN DETEMIR, LISINOPRIL, FAMOTIDINE, NIACIN, FENOFIBRATE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, CYCLOBENZAPRINE, OXYCODONE, HYDROCHLOROTHIAZIDE, ATENOLOL, |
||||
| 2562 | 25285982 |
US |
65 | 2 |
Hypotension, Overdose, Syncope, Weight decreased, Arthralgia, Pain in extremity, Nausea, Headache, |
||||
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, SOTATERCEPT-CSRK, AMBRISENTAN, TADALAFIL, |
||||
| 2563 | 25286001 |
FR |
29 | 1 |
Drug abuse, Alcohol abuse, Overdose, |
||||
ALPRAZOLAM, SERTRALINE, ALCOHOL, ETHYL ALCOHOL, ISOPROPYL ALCOHOL, |
||||
| 2564 | 25286012 |
US |
||
Pneumonia, Influenza, Sinusitis, Hypersensitivity, Drug interaction, Overdose, |
||||
ESLICARBAZEPINE ACETATE, CLINDAMYCIN PHOSPHATE, CLINDAMYCIN, CLINDAMYCIN PHOSPHATE, CLINDAMYCIN, |
||||
| 2565 | 25286081 |
AU |
52 | 1 |
Nausea, Vomiting, Distributive shock, Overdose, |
||||
AMLODIPINE, TELMISARTAN, |
||||
| 2566 | 25286308 |
PK |
||
Mental disorder, Overdose, |
||||
INFLIXIMAB, |
||||
| 2567 | 25286372 |
AU |
64 | 1 |
Blood creatinine increased, Overdose, Suicidal ideation, Toxicity to various agents, |
||||
TELMISARTAN, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, METOPROLOL TARTRATE, METOPROLOL, WARFARIN, ALCOHOL, ETHYL ALCOHOL, ISOPROPYL ALCOHOL, |
||||
| 2568 | 25287263 |
US |
75 | 2 |
Wrong technique in device usage process, Overdose, |
||||
FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, |
||||
| 2569 | 25287425 |
RO |
58 | 2 |
Delayed graft function, Overdose, Pseudohypoaldosteronism, Pulmonary congestion, Immunosuppressant drug level increased, |
||||
TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, PREDNISONE, FUROSEMIDE, |
||||
| 2570 | 25287473 |
US |
18 | |
Generalised tonic-clonic seizure, Gastrointestinal disorder, Acute hepatic failure, Overdose, |
||||
IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, IRON, |
||||
| 2571 | 25287476 |
US |
64 | 1 |
Complication associated with device, Intentional product misuse, Overdose, |
||||
IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, |
||||
| 2572 | 25287776 |
US |
71 | 1 |
Pneumonia, Product prescribing issue, Therapy interrupted, Overdose, Product use in unapproved indication, |
||||
LACOSAMIDE, LACOSAMIDE, |
||||
| 2573 | 25289120 |
US |
39 | 1 |
Distributive shock, Apnoea, Mental status changes, Overdose, |
||||
PROMETHAZINE HYDROCHLORIDE, PROMETHAZINE, AMLODIPINE, CYCLOBENZAPRINE, |
||||
| 2574 | 25289937 |
GB |
17 | 1 |
Overdose, |
||||
OXYCODONE HYDROCHLORIDE, OXYCODONE, PREGABALIN, DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), |
||||
| 2575 | 25280797 |
CA |
||
Crohn^s disease, Treatment failure, Overdose, Intentional product use issue, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, |
||||
| 2576 | 25281143 |
US |
26 | 1 |
Overdose, Tachycardia, |
||||
FENTANYL, DIPHENHYDRAMINE HYDROCHLORIDE, ALPRAZOLAM, |
||||
| 2577 | 25281305 |
DE |
51 | 1 |
Migraine with aura, Oxygen saturation decreased, Overdose, Product availability issue, |
||||
RIZATRIPTAN BENZOATE, RIZATRIPTAN BENZOATE, |
||||
| 2578 | 25281349 |
US |
2 | |
Incorrect dose administered, Overdose, Product dose omission issue, Device malfunction, Product supply issue, Wrong technique in product usage process, Wrong technique in device usage process, |
||||
BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, |
||||
| 2579 | 25282038 |
AU |
||
Distributive shock, Nausea, Vomiting, Overdose, |
||||
TELMISARTAN, AMLODIPINE, |
||||
| 2580 | 25282082 |
FR |
56 | 1 |
Dopamine dysregulation syndrome, Overdose, Drug ineffective, Impulse-control disorder, Drug abuse, Drug dependence, |
||||
PRAMIPEXOLE, PRAMIPEXOLE, LEVODOPA, |
||||
| 2581 | 25282332 |
US |
57 | 2 |
Seizure, Unresponsive to stimuli, Tachycardia, Electrocardiogram QRS complex prolonged, Electrocardiogram QT prolonged, Overdose, |
||||
IBUPROFEN AND DIPHENHYDRAMINE CITRATE, |
||||
| 2582 | 25282999 |
75 | 2 | |
Myelosuppression, Stomatitis, Pharyngeal inflammation, Oral pain, General physical health deterioration, Decreased appetite, Nausea, Eating disorder, Thrombocytopenia, Neutropenia, Anaemia, Overdose, Inappropriate schedule of product administration, |
||||
METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, FOLIC ACID, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, ZOLEDRONIC ACID, |
||||
| 2583 | 25283258 |
US |
||
Toxicity to various agents, Overdose, |
||||
ALPRAZOLAM, GABAPENTIN, OXYCODONE, |
||||
| 2584 | 25283293 |
US |
66 | 1 |
Inappropriate schedule of product administration, Overdose, Incorrect dose administered, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 2585 | 25284087 |
US |
34 | 2 |
Overdose, Inappropriate schedule of product administration, |
||||
| 2586 | 25284097 |
US |
17 | 1 |
Product use issue, Overdose, Inappropriate schedule of product administration, |
||||
| 2587 | 25284595 |
FR |
94 | 1 |
Tuberculosis, Lower respiratory tract congestion, Respiratory disorder, Lung disorder, Wrong product administered, Overdose, Product dispensing error, Product packaging confusion, Fall, |
||||
DAPAGLIFLOZIN, FUROSEMIDE, BISOPROLOL FUMARATE, PANTOPRAZOLE, |
||||
| 2588 | 25284810 |
US |
2 | |
Abortion, Infection, Suicide attempt, Overdose, Drug dependence, Drug abuse, Gastrooesophageal reflux disease, Emotional distress, Maternal exposure during pregnancy, Irritable bowel syndrome, Abdominal discomfort, Gastrointestinal disorder, Dyspepsia, Pain, Euphoric mood, Product prescribing issue, Depression, |
||||
OXYCODONE HYDROCHLORIDE, OXYCODONE HYDROCHLORIDE, OXYCODONE, OXYCODONE HYDROCHLORIDE, OXYCODONE, OXYCODONE HYDROCHLORIDE, OXYCODONE, HYDROCODONE BITARTRATE AND ACETAMINOPHEN, NICOTINE POLACRILEX, NICOTINE, NICOTINE POLACRILEX MINI, NICOTINE POLARILEX, |
||||
| 2589 | 25275975 |
US |
1 | |
Overdose, |
||||
CETIRIZINE HYDROCHLORIDE, |
||||
| 2590 | 25275994 |
GB |
78 | 1 |
Acute left ventricular failure, Overdose, Benign prostatic hyperplasia, Coronary artery occlusion, |
||||
PREGABALIN, |
||||
| 2591 | 25276095 |
US |
59 | 2 |
Overdose, Product dose omission issue, Product dose omission in error, Erythema, Feeling hot, Pruritus, |
||||
DIROXIMEL FUMARATE, |
||||
| 2592 | 25276188 |
PH |
1 | |
Neurotoxicity, Overdose, Self-medication, Toxicity to various agents, |
||||
IVERMECTIN, |
||||
| 2593 | 25276503 |
US |
52 | 1 |
Overdose, Compulsive hoarding, Drug diversion, Drug use disorder, |
||||
| 2594 | 25276592 |
ES |
21 | 1 |
Mental status changes, Arrhythmia, Coma, Sedation, Ventricular tachycardia, Generalised tonic-clonic seizure, Toxicity to various agents, Drug level increased, Overdose, Agitation, |
||||
LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE, |
||||
| 2595 | 25276593 |
AU |
23 | 2 |
Pneumonia aspiration, Electrocardiogram QRS complex prolonged, Depressed level of consciousness, Toxicity to various agents, Sinus tachycardia, Hypotension, Overdose, Drug level increased, |
||||
QUETIAPINE FUMARATE, QUETIAPINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, |
||||
| 2596 | 25277221 |
CA |
||
Adrenal insufficiency, Hypokalaemia, Immunodeficiency, Loss of consciousness, Joint destruction, Polyarthritis, Pregnancy, Exposure during pregnancy, Maternal exposure during pregnancy, Drug tolerance, Therapeutic product effect decreased, Therapy non-responder, Contraindicated product administered, Intentional product use issue, Off label use, Product use in unapproved indication, Intentional product use issue, Overdose, |
||||
RITUXIMAB, RITUXIMAB, RITUXIMAB, ANAKINRA, ANAKINRA, ANAKINRA, ANAKINRA, ANAKINRA, ANAKINRA, ANAKINRA, ANAKINRA, ANAKINRA, ANAKINRA, ANAKINRA, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, SECUKINUMAB, DESOXIMETASONE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G, PREGABALIN, PREGABALIN, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, OXYCODONE, OXYCODONE, OXYCODONE, OXYCODONE, OXYCODONE, OXYCODONE, OXYCODONE, OXYCODONE, OXYCODONE, OXYCODONE, OXYCODONE, OXYCODONE, OXYCODONE, OXYCODONE, OXYCODONE, OXYCODONE, OXYCODONE, PREGABALIN, PREGABALIN, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, ERGOCALCIFEROL, ERGOCALCIFEROL, |
||||
| 2597 | 25277258 |
US |
23 | 2 |
Encephalopathy, Acute hepatic failure, Brain oedema, Mental status changes, Somnolence, Toxicity to various agents, Overdose, Exposure during pregnancy, |
||||
ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 2598 | 25277647 |
US |
||
Dyspepsia, Product use in unapproved indication, Drug ineffective, Overdose, |
||||
ESOMEPRAZOLE MAGNESIUM, |
||||
| 2599 | 25277796 |
US |
1 | |
Headache, Visual impairment, Overdose, |
||||
EPOPROSTENOL SODIUM, EPOPROSTENOL SODIUM, EPOPROSTENOL SODIUM, EPOPROSTENOL SODIUM, EPOPROSTENOL SODIUM, EPOPROSTENOL SODIUM, EPOPROSTENOL SODIUM, EPOPROSTENOL SODIUM, TADALAFIL, TADALAFIL, TADALAFIL, TADALAFIL, AMBRISENTAN, AMBRISENTAN, AMBRISENTAN, AMBRISENTAN, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, |
||||
| 2600 | 25277810 |
US |
39 | 1 |
Distributive shock, Overdose, |
||||
AMLODIPINE BESYLATE, PROMETHAZINE, CYCLOBENZAPRINE, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-10-30